A Johnson & Johnson executive said in a conference call that the number of surgeries has remained stable, and “we have seen no signs of a significant slowdown in demand.”

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.